| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |